These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18243516)

  • 61. Outcomes of electrical stimulation of the neurogenic bladder: results of a two-year follow-up study.
    Radziszewski K
    NeuroRehabilitation; 2013; 32(4):867-73. PubMed ID: 23867413
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
    Stöhrer M; Mürtz G; Kramer G; Schnabel F; Arnold EP; Wyndaele JJ;
    Eur Urol; 2007 Jan; 51(1):235-42. PubMed ID: 16698176
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Video-urodynamic studies on 1800 patients with neurogenic bladder].
    JU YH; LIAO LM; LI D; FU G; LIANG WL; XIONG ZS; WU J; SHI WB; HAN CS
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1525-8. PubMed ID: 19094643
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term tolerability of tolterodine extended release in children 5-11 years of age: results from a 12-month, open-label study.
    Nijman RJ; Borgstein NG; Ellsworth P; Siggaard C
    Eur Urol; 2007 Nov; 52(5):1511-6. PubMed ID: 17574729
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Follow-up at 24 months after treatment of overactive bladder with 0.2 % sodium chondroitin sulfate].
    Gauruder-Burmester A; Popken G
    Aktuelle Urol; 2009 Nov; 40(6):355-9. PubMed ID: 19693752
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions.
    Bagi P; Biering-Sørensen F
    Scand J Urol Nephrol; 2004; 38(6):495-8. PubMed ID: 15841785
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Can Oral Fesoterodine Be an Alternative for Intravesical Oxybutynin Instillations in Children with Neuropathic Bladder Dysfunction?
    van den Heijkant M; De Coster K; Jansen K; Bogaert G
    Urol Int; 2019; 103(2):202-210. PubMed ID: 31117096
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combined intravesical and oral oxybutynin chloride in adult patients with spinal cord injury.
    Pannek J; Sommerfeld HJ; Bötel U; Senge T
    Urology; 2000 Mar; 55(3):358-62. PubMed ID: 10699610
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Urodynamic effects and safety of modified intravesical oxybutynin chloride in patients with neurogenic detrusor overactivity: 3 years experience.
    Saito M; Watanabe T; Tabuchi F; Otsubo K; Satoh K; Miyagawa I
    Int J Urol; 2004 Aug; 11(8):592-6. PubMed ID: 15285747
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Trospium chloride in patients with detrusor overactivity: meta-analysis of placebo-controlled, randomized, double-blind, multi-center clinical trials on the efficacy and safety of 20 mg trospium chloride twice daily.
    Fröhlich G; Bulitta M; Strösser W
    Int J Clin Pharmacol Ther; 2002 Jul; 40(7):295-303. PubMed ID: 12139206
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Drug development for pediatric neurogenic bladder dysfunction: dosing, endpoints, and study design.
    Momper JD; Karesh A; Green DJ; Hirsch M; Khurana M; Lee J; Kim MJ; Mulugeta Y; Sachs HC; Yao L; Burckart GJ
    J Clin Pharmacol; 2014 Nov; 54(11):1239-46. PubMed ID: 24922179
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test].
    Fröhlich G; Burmeister S; Wiedemann A; Bulitta M
    Arzneimittelforschung; 1998 May; 48(5):486-91. PubMed ID: 9638316
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Are oxybutynin and trospium efficacious in the treatment of detrusor overactivity in spinal cord injury patients?
    Hadiji N; Previnaire JG; Benbouzid R; Robain G; Leblond C; Mieusset R; Enjalbert M; Soler JM
    Spinal Cord; 2014 Sep; 52(9):701-5. PubMed ID: 25047051
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Experience with application of trospium chloride in patients with neurogenic detrusor overactivity].
    Shvarts PG; Kadykov AS; Shvedkov VV; Timerbaeva SL; Polevaia EV; Mulach AN
    Urologiia; 2009; (5):24-9. PubMed ID: 20213911
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The use of intravesical oxybutynin chloride in children with neurogenic bladder.
    Greenfield SP; Fera M
    J Urol; 1991 Aug; 146(2 ( Pt 2)):532-4. PubMed ID: 1861294
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of intravesical oxybutynin on the ice water test and on electrical perception thresholds in patients with neurogenic detrusor overactivity.
    Van Meel TD; De Wachter S; Wyndaele JJ
    Neurourol Urodyn; 2010 Mar; 29(3):391-4. PubMed ID: 19787712
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy, tolerability, and safety of oxybutynin chloride in pediatric neurogenic bladder with spinal dysraphism: a retrospective, multicenter, observational study.
    Lee JH; Kim KR; Lee YS; Han SW; Kim KS; Song SH; Baek M; Park K
    Korean J Urol; 2014 Dec; 55(12):828-33. PubMed ID: 25512818
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intravesical oxybutynin for children with poorly compliant neurogenic bladder: a systematic review.
    Guerra LA; Moher D; Sampson M; Barrowman N; Pike J; Leonard M
    J Urol; 2008 Sep; 180(3):1091-7. PubMed ID: 18639290
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia--a double-blind, placebo-controlled clinical trial.
    Stöhrer M; Madersbacher H; Richter R; Wehnert J; Dreikorn K
    Spinal Cord; 1999 Mar; 37(3):196-200. PubMed ID: 10213329
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Trospium chloride in the treatment of idiopathic and neurogenic detrusor overactivity].
    Mazo EB; Krivoborodov GG; Shkol'nikov ME; Babanina GA; Kozyrev SV; Korshunov ES
    Urologiia; 2005; (4):56-9. PubMed ID: 16158750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.